시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 의료기기 상환 시장 보고서(2025년)
Medical Devices Reimbursement Global Market Report 2025
상품코드 : 1693251
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,496,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,390,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,284,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의료기기 상환 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 9.1%의 연평균 성장률(CAGR)로 9,248억 3,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 가치 기반 의료 모델, 정밀 의료에 대한 수요 증가, 세계 의료 안전에 대한 노력, 환자 중심 의료에 대한 관심, 의료 기술 평가(HTA)와의 연계, 의료에 대한 정부 투자 등에 기인하는 것으로 분석됩니다. 예측 기간의 주요 동향으로는 디지털 헬스 기술 통합, 제조업체와 지불자의 협력 계약, 실제 증거와 의료 경제 데이터에 대한 중요성, 성과 보상 모델 채택, 가치 평가 프레임워크 도입, 위험분담 계약의 발전 등을 꼽을 수 있습니다.

최소침습수술에 대한 수요 증가는 의료기기 상환 시장의 성장을 촉진할 것으로 예상됩니다. 최소침습수술(MIS)은 기존의 개복수술에 비해 환자의 신체에 더 적은 손상을 입히고 수술을 하기 위해 특수한 기술과 도구를 사용하는 의료적 접근 방식입니다. 최소침습수술에 대한 의료기기의 급여화는 첨단 수술에 대한 환자 접근성 향상과 입원기간 단축을 통한 의료비 절감 등의 이점을 제공합니다. 예를 들어, 미국 성형외과학회(ASPS)는 2023년 9월에 보툴리눔톡신 A형(보톡스, 디스포트, 제오민 등)을 이용한 최소침습수술이 2023년에 471만 5716건 시행될 것으로 예상되며, 이는 전년 대비 6% 증가한 수치라고 보고했습니다. 또한, 피부 필러가 널리 사용되어 3,441,534건의 시술이 이루어졌으며, 2022년 대비 4% 증가한 것으로 나타났습니다. 따라서 최소침습 수술에 대한 수요가 증가하면서 의료기기 상환 시장의 성장을 견인하고 있습니다.

만성질환의 증가는 의료기기 상환 시장의 성장을 촉진할 것으로 예상됩니다. 만성질환은 관리할 수 있지만 완치할 수 없는 장기적인 질환입니다. 의료기기 환급은 경제적 부담을 줄이고, 접근성을 보장하며, 혁신을 촉진하고, 환자 예후를 개선함으로써 만성질환 관리에 중요한 역할을 합니다. 예를 들어, 2024년 9월 영국에 기반을 둔 심장 및 순환기 질환 전문 자선단체인 영국심장재단(British Heart Foundation)은 영국에서 약 760만 명이 이러한 질환을 앓고 있다고 보고했습니다. 이 숫자는 2030년까지 100만 명, 2040년까지 200만 명 증가할 것으로 예측됩니다. 따라서 만성질환의 유병률 증가는 의료기기 상환 시장의 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Medical device reimbursement is the procedure through which healthcare providers receive payment from insurance plans or payers for supplying patients with medically necessary devices. This entails assessing the device's cost, evaluating its efficacy, and engaging in negotiations with payers to secure insurance coverage.

The primary contributors to medical device reimbursement are public and private entities. Public payers refer to government-funded organizations or entities tasked with financing and overseeing healthcare services for a designated population or country. Hospitals, outpatient facilities, and various healthcare settings submit claims for both underpaid and fully reimbursed services.

The medical device reimbursement market research report is one of a series of new reports from The Business Research Company that provides medical device reimbursement market statistics, including medical device reimbursement industry global market size, regional shares, competitors with a medical device reimbursement market share, detailed medical device reimbursement market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reimbursement industry. This medical device reimbursement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical devices reimbursement market size has grown strongly in recent years. It will grow from $602.26 billion in 2024 to $653.64 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to government healthcare policies, increased disease burden, patient access and affordability, healthcare cost containment, provider and payer collaboration, increasing regulatory compliance.

The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $924.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to value-based healthcare models, rising demand for precision medicine, global health security initiatives, focus on patient-centric care, collaboration with health technology assessment (hta), government investments in healthcare. Major trends in the forecast period include integration of digital health technologies, collaborative agreements between manufacturers and payers, focus on real-world evidence and health economics data, adoption of pay-for-performance models, value assessment frameworks implementation, advancements in risk-sharing agreements.

The increasing demand for minimally invasive surgeries is expected to drive the growth of the medical device reimbursement market. Minimally invasive surgery (MIS) is a medical approach that uses specialized techniques and tools to perform surgeries with less disruption to the patient's body compared to traditional open surgery. Medical device reimbursement for minimally invasive surgeries offers benefits such as improved patient access to advanced procedures and reduced healthcare costs through shorter hospital stays. For example, in September 2023, the American Society of Plastic Surgeons (ASPS), a US-based organization, reported that 4,715,716 minimally invasive procedures using botulinum toxin type A (including Botox, Dysport, and Xeomin) were performed in 2023, marking a 6% increase from the previous year. Additionally, dermal fillers were widely used, with 3,441,534 procedures performed, reflecting a 4% rise from 2022. Therefore, the rising demand for minimally invasive surgeries is fueling the growth of the medical device reimbursement market.

The increasing prevalence of chronic diseases is expected to drive the growth of the medical device reimbursement market. Chronic diseases are long-term conditions that can be managed but not cured. Reimbursement for medical devices plays a crucial role in managing chronic diseases by ensuring accessibility, fostering innovation, and improving patient outcomes, while also reducing economic burdens. For instance, in September 2024, the British Heart Foundation, a UK-based charity focused on heart and circulatory diseases, reported that about 7.6 million people in the UK are living with such conditions. This number is projected to rise by 1 million by 2030 and by 2 million by 2040. Therefore, the increasing prevalence of chronic diseases is driving the growth of the medical device reimbursement market.

Major players in the medical device reimbursement market are strategically focusing on technological advancements, exemplified by the development of electronic medical records (EMRs), to maintain their market positions. Electronic medical records serve as digital versions of a patient's paper medical charts and play a crucial role in supporting reimbursement claims by ensuring the medical necessity and appropriate utilization of devices. For instance, in April 2023, Wemex Corporation, a Japan-based IT solutions company, introduced the medicom-HRf hybrid cloud, an integrated EMR system utilizing cloud technology to facilitate location-free operations for clinics. Hybrid cloud solutions such as Medicom-HRf seamlessly integrate various data sources, including patient records, medical billing, insurance claims, and regulatory information. This integration offers a comprehensive view of a patient's treatment and billing history, crucial for accurate reimbursement. Medical device companies can leverage such systems to access up-to-date information on insurance coverage, reimbursement rates, and claim status.

In January 2022, Centene Corporation, a US-based managed care company, completed the acquisition of Magellan Health Inc. for an undisclosed amount. This strategic move enables Centene Corporation to deliver innovative and integrated healthcare solutions, resulting in improved health outcomes at lower costs, particularly for complex and high-cost health treatments. Magellan Health Inc., as a managed care company, brings expertise in offering solutions for health plans and reimbursement management, covering a spectrum of devices and healthcare services within the healthcare landscape.

Major companies operating in the medical devices reimbursement market report are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Axa S.A., Assicurazioni Generali SpA, Humana Inc., Reliance Nippon Life Insurance Company Limited, MetLife Services and Solutions LLC, Aetna Inc., New York Life Insurance, Nationwide Mutual Insurance Company, American International Group Inc., Allstate Insurance Company, BNP Paribas S.A., Zurich Insurance Group Ltd., Aegon Life Insurance Company, Aviva PLC, WellCare Health Plans Inc., Pacific Life Insurance Company, Allianz SE, Bright House Financial Inc., Globe Life Inc., Munich Re Group, Symetra Life Insurance Company, Sumitomo Life Insurance Company, NAMSA Inc., Colonial Penn Life Insurance Company, Musculoskeletal Clinical Regulatory Advisers LLC, Assurity Life Insurance

North America was the largest region in the medical devices reimbursement market in 2024. The regions covered in the medical devices reimbursement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical devices reimbursement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical devices reimbursement market includes revenues earned by entities by providing services such as coding and billing services, claims processing, coverage determination, benefit verification, coding and billing training, and pre-authorization and pre-certification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Devices Reimbursement Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical devices reimbursement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical devices reimbursement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical devices reimbursement market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Medical Devices Reimbursement Market Characteristics

3. Medical Devices Reimbursement Market Trends And Strategies

4. Medical Devices Reimbursement Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Medical Devices Reimbursement Growth Analysis And Strategic Analysis Framework

6. Medical Devices Reimbursement Market Segmentation

7. Medical Devices Reimbursement Market Regional And Country Analysis

8. Asia-Pacific Medical Devices Reimbursement Market

9. China Medical Devices Reimbursement Market

10. India Medical Devices Reimbursement Market

11. Japan Medical Devices Reimbursement Market

12. Australia Medical Devices Reimbursement Market

13. Indonesia Medical Devices Reimbursement Market

14. South Korea Medical Devices Reimbursement Market

15. Western Europe Medical Devices Reimbursement Market

16. UK Medical Devices Reimbursement Market

17. Germany Medical Devices Reimbursement Market

18. France Medical Devices Reimbursement Market

19. Italy Medical Devices Reimbursement Market

20. Spain Medical Devices Reimbursement Market

21. Eastern Europe Medical Devices Reimbursement Market

22. Russia Medical Devices Reimbursement Market

23. North America Medical Devices Reimbursement Market

24. USA Medical Devices Reimbursement Market

25. Canada Medical Devices Reimbursement Market

26. South America Medical Devices Reimbursement Market

27. Brazil Medical Devices Reimbursement Market

28. Middle East Medical Devices Reimbursement Market

29. Africa Medical Devices Reimbursement Market

30. Medical Devices Reimbursement Market Competitive Landscape And Company Profiles

31. Medical Devices Reimbursement Market Other Major And Innovative Companies

32. Global Medical Devices Reimbursement Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Devices Reimbursement Market

34. Recent Developments In The Medical Devices Reimbursement Market

35. Medical Devices Reimbursement Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기